|
Bitterman DS,
Winter KA,
Hong TS,
Fuchs CS,
Regine WF,
Abrams RA,
Safran H,
Hoffman JP,
Benson AB 3rd,
Kasunic T,
Mulcahy M,
Strauss JF,
DiPetrillo T,
Stella PJ,
Chen Y,
Plastaras JP,
Crane CH. Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704.
Int J Radiat Oncol Biol Phys. 2021 Jan;109(1)
:201-211. PMC ID:PMC7736166. |
Henry LR,
Sigurdson E,
Ross EA,
Lee JS,
Watson JC,
Cheng JD,
Freedman GM,
Konski A,
Hoffman JP. Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.
Ann Surg Oncol. 2020 Nov 25
. |
Reyngold M,
Winter KA,
Regine WF,
Abrams RA,
Safran H,
Hoffman JP,
Mowat RB,
Hayes JP,
Kessel IL,
DiPetrillo T,
Narayan S,
Chen Y,
Ben-Josef E,
Delouya G,
Suh JH,
Meyer J,
Haddock MG,
Feldman M,
Gaur R,
Yost K,
Peterson RA,
Sherr DL,
Moughan J,
Crane CH. Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.
Oncologist. 2020 Mar;25(3)
:e477-e483. PMC ID:PMC7066692. |
Goel N,
Nadler A,
Reddy S,
Hoffman JP,
Pitt HA. Biliary microbiome in pancreatic cancer: alterations with neoadjuvant therapy.
HPB (Oxford). 2019 May 14;21(12)
:1753-1760. |
Fareed MM,
DeMora L,
Esnaola NF,
Denlinger CS,
Karachristos A,
Ross EE,
Hoffman J,
Meyer JE. Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas.
J Gastrointest Oncol. 2018 Aug;9(4)
:762-768. PMC ID:PMC6087856. |
Goel N,
D'Souza JW,
Ruth KJ,
Milestone B,
Karachristos A,
Nagarathinam R,
Cooper H,
Hoffman J,
Reddy S. The Utility of Preoperative Vascular Grading in Patients Undergoing Surgery First for Pancreatic Cancer: Does Radiologic Arterial or Venous Involvement Predict Pathologic Margin Status?.
J Oncol. 2018 Aug;2018
:7675262. PMC ID:PMC6110012. |
Regine WF,
Winter K,
Abrams RA,
Safran H,
Kessel IL,
Chen Y,
Fugazzi JA,
Donnelly ED,
DiPetrillo TA,
Narayan S,
Plastaras JP,
Gaur R,
Delouya G,
Suh JH,
Meyer JE,
Haddock MG,
Didolkar MS,
Padula GDA,
Johnson D,
Hoffman JP,
Crane CH. Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704.
Advances in Radiation Oncology. 2018 Apr-Jun;3(2)
:154-162. PMC ID:PMC6000159. |
Shaikh T,
Wang LS,
Egleston B,
Burki M,
Hoffman JP,
Cohen SJ,
Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer.
Am J Clin Oncol. 2018 Jan;41(1)
:59-64. PMC ID:PMC4769977. |
Franco-Barraza J,
Francescone R,
Luong T,
Shah N,
Madhani R,
Cukierman G,
Dulaimi E,
Devarajan K,
Egleston BL,
Nicolas E,
Katherine Alpaugh R,
Malik R,
Uzzo RG,
Hoffman JP,
Golemis EA,
Cukierman E. Matrix-regulated integrin alphavbeta5 maintains alpha5beta1-dependent desmoplastic traits prognostic of neoplastic recurrence.
Elife. 2017 Jan 31;6
. PMC ID:PMC5283834. |
Beglyarova N,
Banina E,
Zhou Y,
Mukhamadeeva R,
Andrianov G,
Bobrov E,
Lysenko E,
Skobeleva N,
Gabitova L,
Restifo D,
Pressman M,
Serebriiskii IG,
Hoffman JP,
Paz K,
Behrens D,
Khazak V,
Jablonski SA,
Weiner LM,
Golemis EA,
Astsaturov I. Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer.
Clin Cancer Res. 2016 Dec 15;22(24)
:6153-6163. PMC ID:PMC5161635. |
Hoffman JP,
Reddy SS. Is It Time for Total Neoadjuvant Therapy for Patients With Resectable Pancreatic Adenocarcinoma?.
J Oncol Pract. 2016 Sep;12(9)
:780-1. |
Katz MH,
Shi Q,
Ahmad SA,
Herman JM,
Marsh RW,
Collisson E,
Schwartz L,
Frankel W,
Martin R,
Conway W,
Truty M,
Kindler H,
Lowy AM,
Bekaii-Saab T,
Philip P,
Talamonti M,
Cardin D,
LoConte N,
Shen P,
Hoffman JP,
Venook AP. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
JAMA Surg. 2016 Aug 17;151(8)
:e161137. PMC ID:PMC5210022. |
Shaikh T,
Wang LS,
Egleston B,
Burki M,
Hoffman JP,
Cohen SJ,
Meyer JE. Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer.
Pract Radiat Oncol. 2016 Jul-Aug;6(4)
:e107-15. |
Li D,
Moughan J,
Crane C,
Hoffman JP,
Regine WF,
Abrams RA,
Safran H,
Liu C,
Chang P,
Freedman GM,
Winter KA,
Guha C,
Abbruzzese JL. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3)
:554-60. PMC ID:PMC4876948. |
Wang LS,
Shaikh T,
Handorf EA,
Hoffman JP,
Cohen SJ,
Meyer JE. Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
Pract Radiat Oncol. 2015 Sep-Oct;5(5)
:e457-63. PMC ID:PMC4814166. |
Chen KT,
Devarajan K,
Hoffman JP. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma.
Ann Surg Oncol. 2015 Apr;22(4)
:1185-9. |
Hall MJ,
Innocent J,
Rybak C,
Veloski C,
Scott WJ,
Wu H,
Ridge JA,
Hoffman JP,
Borghaei H,
Turaka A,
Daly MB. Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.
Appl Clin Genet. 2015 ;8
:69-73. PMC ID:PMC4337709. |
Reddy SS,
Hoffman JP. "Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of borderline resectable disease": a commentary on the article published by Kelly et al. In the Journal of Gastrointestinal Surgery 17:1209 (2013) [Comment; Letter].
J Gastrointest Surg. 2014 Sep;18(9)
:1719. |
Tempero MA,
Malafa MP,
Behrman SW,
Benson AB 3rd,
Casper ES,
Chiorean EG,
Chung V,
Cohen SJ,
Czito B,
Engebretson A,
Feng M,
Hawkins WG,
Herman J,
Hoffman JP,
Ko A,
Komanduri S,
Koong A,
Lowy AM,
Ma WW,
Merchant NB,
Mulvihill SJ,
Muscarella P 2nd,
Nakakura EK,
Obando J,
Pitman MB,
Reddy S,
Sasson AR,
Thayer SP,
Weekes CD,
Wolff RA,
Wolpin BM,
Burns JL,
Freedman-Cass DA. Pancreatic adenocarcinoma, version 2.2014.
J Natl Compr Canc Netw. 2014 Aug;12(8)
:1083-93. |
Martin LP,
Sill M,
Shahin MS,
Powell M,
DiSilvestro P,
Landrum LM,
Gaillard SL,
Goodheart MJ,
Hoffman J,
Schilder RJ. A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol. 2014 Mar;132(3)
:526-30. |
Chen KT,
Devarajan K,
Milestone BN,
Cooper HS,
Denlinger C,
Cohen SJ,
Meyer JE,
Hoffman JP. Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?.
Ann Surg Oncol. 2014 Feb;21(2)
:662-9. |
Papavasiliou P,
Hoffman JP,
Cohen SJ,
Meyer JE,
Watson JC,
Chun YS. Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.
HPB (Oxford). 2014 Jan;16(1)
:34-9. PMC ID:PMC3892312. |
Chen KT,
Kim PD,
Jones KA,
Devarajan K,
Patel BB,
Hoffman JP,
Ehya H,
Huang M,
Watson JC,
Tokar JL,
Yeung AT. Potential prognostic biomarkers of pancreatic cancer.
Pancreas. 2014 Jan;43(1)
:22-7. PMC ID:PMC3859961. |
Arrangoiz R,
Papavasiliou P,
Singla S,
Siripurapu V,
Li T,
Watson JC,
Hoffman JP,
Farma JM. Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation.
Am J Surg. 2013 Sep;206(3)
:333-9. |
Kim J,
Hoffman JP,
Alpaugh RK,
Rhim AD,
Reichert M,
Stanger B,
Furth EE,
Sepulveda AR,
Yuan CX,
Won KJ,
Donahue G,
Sands J,
Gumbs AA,
Zaret KS. An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression.
Cell Reports. 2013 Jun;3(6)
:2088-2099. PMC ID:PMC 3726210. |
Berger AC,
Winter K,
Hoffman JP,
Regine WF,
Abrams RA,
Safran H,
Freedman GM,
Benson AB,
MacDonald J,
Willett CG. Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 <= 90 U/mL and Comparison to the CONKO-001 Trial.
International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(3)
:E291-E297. |
Tempero MA,
Arnoletti JP,
Behrman SW,
Ben-Josef E,
Benson AB,
Casper ES,
Cohen SJ,
Czito B,
Ellenhorn JDI,
Hawkins WG,
Herman J,
Hoffman JP,
Ko A,
Komanduri S,
Koong A,
Ma WW,
Malafa MP,
Merchant NB,
Mulvihill SJ,
Muscarella P,
Nakakura EK,
Obando J,
Pitman MB,
Sasson AR,
Tally A,
Thayer SR,
Whiting S,
Wolff RA,
Wolpin BM,
Freedman-Cass DA,
Shead DA. Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines.
Journal of the National Comprehensive Cancer Network. 2012 Jun;10(6)
:703-713. |
Wang D,
Zhang Q,
Blanke CD,
Demetri GD,
Heinrich MC,
Watson JC,
Hoffman JP,
Okuno S,
Kane JM,
von Mehren M,
Eisenberg BL. Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132.
Annals of Surgical Oncology. 2012 Apr;19(4)
:1074-1080. |
Canter D,
Simhan J,
Smaldone MC,
Lebed B,
Tokar JL,
Wu KN,
Uzzo RG,
Gustafson KS,
Patchefsky AS,
Plimack ER,
Hoffman JP,
Kutikov A. Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas.
Urology. 2012 Feb;79(2)
:e9-10. |
Abrams RA,
Winter KA,
Regine WF,
Safran H,
Hoffman JP,
Lustig R,
Konski AA,
Benson AB,
Macdonald JS,
Rich TA,
Willett CG. FAILURE TO ADHERE TO PROTOCOL SPECIFIED RADIATION THERAPY GUIDELINES WAS ASSOCIATED WITH DECREASED SURVIVAL IN RTOG 9704-A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS.
International Journal of Radiation Oncology Biology Physics. 2012 Feb;82(2)
:809-816. PMC ID:PMC133855. |
Gumbs AA,
Tsai TJ,
Hoffman JP. Initial experience with laparoscopic hepatic resection at a comprehensive cancer center.
Surgical Endoscopy. 2012 Feb;26(2)
:480-7. |
Papavasiliou P,
Arrangoiz R,
Zhu F,
Chun YS,
Edwards K,
Hoffman JP. The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery.
Int J Surg Oncol. 2012 ;2012
:538769. PMC ID:PMC3303700. |
Rich TA,
Winter K,
Safran H,
Hoffman JP,
Erickson B,
Anne PR,
Myerson RJ,
Cline-Burkhardt VJM,
Perez K,
Willett C. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.
Oncotargets and Therapy. 2012 ;5
:161-170. PMC ID:PMC3430391. |
Chun YS,
Cooper HS,
Cohen SJ,
Konski A,
Burtness B,
Denlinger CS,
Astsaturov I,
Hall MJ,
Hoffman JP. Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer.
Annals of Surgical Oncology. 2011 Dec;18(13)
:3601-3607. |
Showalter TN,
Winter KA,
Berger AC,
Regine WF,
Abrams RA,
Safran H,
Hoffman JP,
Benson AB,
MacDonald JS,
Willett CG. THE INFLUENCE OF TOTAL NODES EXAMINED, NUMBER OF POSITIVE NODES, AND LYMPH NODE RATIO ON SURVIVAL AFTER SURGICAL RESECTION AND ADJUVANT CHEMORADIATION FOR PANCREATIC CANCER: A SECONDARY ANALYSIS OF RTOG 9704.
International Journal of Radiation Oncology Biology Physics. 2011 Dec;81(5)
:1328-1335. PMC ID:PMC3038247. |
Gumbs AA,
Leventhal A,
Hoffman JP. Laparoscopic right hepatectomy and partial resection of the diaphragm for liver metastases.
Surgical Endoscopy and Other Interventional Techniques. 2011 Oct;25(10)
:3441-3443. |
Gumbs AA,
Rodriguez-Rivera AM,
Hoffman JP. Minimally invasive pancreatic surgery of the entire gland: initial experience.
Minerva Chirurgica. 2011 Aug;66(4)
:269-280. |
Regine WF,
Winter KA,
Abrams R,
Safran H,
Hoffman JP,
Konski A,
Benson AB,
Macdonald JS,
Rich TA,
Willett CG. Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the US Intergroup/RTOG 9704 Phase III Trial.
Annals of Surgical Oncology. 2011 May;18(5)
:1319-1326. |
Gumbs AA,
Rivera AMR,
Milone L,
Hoffman JP. Laparoscopic Pancreatoduodenectomy: A Review of 285 Published Cases.
Annals of Surgical Oncology. 2011 May;18(5)
:1335-1341. |
Gumbs AA,
Hoffman JP. Laparoscopic completion radical cholecystectomy for T2 gallbladder cancer.
Surgical Endoscopy and Other Interventional Techniques. 2010 Dec;24(12)
:3221-3223. |
Chun YS,
Milestone BN,
Watson JC,
Cohen SJ,
Burtness B,
Engstrom PF,
Haluszka O,
Tokar JL,
Hall MJ,
Denlinger CS,
Astsaturov I,
Hoffman JP. Defining Venous Involvement in Borderline Resectable Pancreatic Cancer.
Annals of Surgical Oncology. 2010 Nov;17(11)
:2832-2838. |
Tempero MA,
Arnoletti JP,
Behrman S,
Ben-Josef E,
Benson AB,
Berlin JD,
Cameron JL,
Casper ES,
Cohen SJ,
Duff M,
Ellenhorn JDI,
Hawkins WG,
Hoffman JP,
Kuvshinoff BW,
Malafa MP,
Muscarella P,
Nakakura EK,
Sasson AR,
Thayer SP,
Tyler DS. Pancreatic Adenocarcinoma.
Journal of the National Comprehensive Cancer Network. 2010 Sep;8(9)
:972-+. PMC ID:PMC3135380. |
Gumbs AA,
Hoffman JP. Laparoscopic radical cholecystectomy and Roux-en-Y choledochojejunostomy for gallbladder cancer.
Surgical Endoscopy and Other Interventional Techniques. 2010 Jul;24(7)
:1766-1768. |
Landry J,
Catalano PJ,
Staley C,
Harris W,
Hoffman J,
Talamonti M,
Xu N,
Cooper H,
Benson AB. Randomized Phase II Study of Gemcitabine Plus Radiotherapy Versus Gemcitabine, 5-Fluorouracil, and Cisplatin Followed by Radiotherapy and 5-Fluorouracil for Patients With Locally Advanced, Potentially Resectable Pancreatic Adenocarcinoma.
Journal of Surgical Oncology. 2010 Jun;101(7)
:587-592. |
Hoffman JP. Status of Neoadjuvant Therapy for Resectable Pancreatic Cancer.
Surgical Oncology Clinics of North America. 2010 Apr;19(2)
:411-+. |
Ke E,
Patel BB,
Liu T,
Li XM,
Haluszka O,
Hoffman JP,
Ehya H,
Young NA,
Watson JC,
Weinberg DS,
Nguyen MT,
Cohen SJ,
Meropol NJ,
Litwin S,
Tokar JL,
Yeung AT. Proteomic analyses of pancreatic cyst fluids.
Pancreas. 2009 Mar;38(2)
:e33-42. PMC ID:PMC2681236. |
Eisenberg BL,
Harris J,
Blanke CD,
Demetri GD,
Heinrich MC,
Watson JC,
Hoffman JP,
Okuno S,
Kane JM,
von Mehren M. Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665.
Journal of Surgical Oncology. 2009 Jan;99(1)
:42-47. PMC ID:PMC2606912. |
Hoffman JP,
Stitzenberg KB. Preoperative versus postoperative adjuvant therapy for adenocarcinoma of the pancreas.
Adv Surg. 2009 ;43
:189-98. |
Berger AC,
Garcia M,
Hoffman JP,
Regine WF,
Abrams RA,
Safran H,
Konski A,
Benson AB,
MacDonald J,
Willett CG. Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704.
Journal of Clinical Oncology. 2008 Dec;26(36)
:5918-5922. |
Cohen SJ,
Alpaugh RK,
Palazzo I,
Meropol NJ,
Rogatko A,
Xu Z,
Hoffman JP,
Weiner LM,
Cheng JD. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Pancreas. 2008 Aug;37(2)
:154-8. |
Stitzenberg KB,
Watson JC,
Roberts A,
Kagan SA,
Cohen SJ,
Konski AA,
Hoffman JP. Survival after pancreatectomy with major arterial resection and reconstruction.
Ann Surg Oncol. 2008 May;15(5)
:1399-406. |
Brown KM,
Siripurapu V,
Davidson M,
Cohen SJ,
Konski A,
Watson JC,
Li T,
Ciocca V,
Cooper H,
Hoffman JP. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Am J Surg. 2008 Mar;195(3)
:318-21. |
Regine WF,
Winter KA,
Abrams RA,
Safran H,
Hoffman JP,
Konski A,
Benson AB,
Macdonald JS,
Kudrimoti MR,
Fromm ML,
Haddock MG,
Schaefer P,
Willett CG,
Rich TA. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma - A randomized controlled trial.
JAMA-Journal of the American Medical Association. 2008 Mar;299(9)
:1019-1026. |
Small W Jr,
Berlin J,
Freedman GM,
Lawrence T,
Talamonti MS,
Mulcahy MF,
Chakravarthy AB,
Konski AA,
Zalupski MM,
Philip PA,
Kinsella TJ,
Merchant NB,
Hoffman JP,
Benson AB,
Nicol S,
Xu RM,
Gill JF,
McGinn CJ. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
J Clin Oncol. 2008 Feb 20;26(6)
:942-7. |
Hoffman JP,
Willett C,
Cohen SJ. Pancreas cancer: clinical management.
Principles and practice of gastrointestinal oncology. 2008
:377-394. |
Cordera F,
Arciero CA,
Li T,
Watson JC,
Hoffman JP. Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma.
Ann Surg Oncol. 2007 Aug;14(8)
:2330-6. |
Quiros RM,
Brown KM,
Hoffman JP. Neoadjuvant therapy in pancreatic cancer.
Cancer Invest. 2007 Jun;25(4)
:267-73. |
Berencsi K,
Meropol NJ,
Hoffman JP,
Sigurdson E,
Giles L,
Rani P,
Somasundaram R,
Zhang TQ,
Kalabis J,
Caputo L,
Furth E,
Swoboda R,
Marincola F,
Herlyn D. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
Cancer Immunology Immunotherapy. 2007 Mar;56(3)
:359-370. |
Farma JM,
Hoffman JP. Nonneoplastic celiac axis occlusion in patients undergoing pancreaticoduodenectomy.
American Journal of Surgery. 2007 Mar;193(3)
:341-344. |
Henry LR,
Sigurdson E,
Ross EA,
Lee JS,
Watson JC,
Cheng JD,
Freedman GM,
Konski A,
Hoffman JP. Resection of isolated pelvic recurrences after colorectal surgery: Long-term results and predictors of improved clinical outcome.
Annals of Surgical Oncology. 2007 Mar;14(3)
:1081-1091. |
Movsas B,
Diratzouian H,
Hanlon A,
Cooper H,
Freedman G,
Konski A,
Sigurdson E,
Hoffman J,
Meropol NJ,
Weiner LM,
Coia L,
Lanciano R,
Stein J,
Kister D,
Eisenberg B. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Oct;29(5)
:435-441. |
Cohen SJ,
Alpaugh RK,
Gross S,
O'Hara SM,
Smirnov DA,
Ferstappen Lwmm,
Allard WJ,
Bilbee M,
Cheng JD,
Hoffman JP,
Lewis NL,
Pellegrino A,
Rogatko A,
Sigurdson E,
Wang H,
Watson JC,
Weiner LM,
Meropol NJ. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Clinical Colorectal Cancer. 2006 Jul;6(2)
:125-132. |
Hoffman JP. Letter to the editors.
J Gastrointest Surg. 2006 Jul-Aug;10(7)
:1095. |
Arciero CA,
Joseph N,
Watson JC,
Hoffman JP. Partial stomach-partitioning gastrojejunostomy for malignant duodenal obstruction.
AMERICAN JOURNAL OF SURGERY. 2006 Mar;191(3)
:428-432. |
Talamonti MS,
Small W,
Mulcahy MF,
Wayne JD,
Attaluri V,
Colletti LM,
Zalupski MM,
Hoffman JP,
Freedman GM,
Kinsella TJ,
Philip PA,
McGinn CJ. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
Annals of Surgical Oncology 13 (2): 150-158 Feb 2006. 2006 Feb;13(2)
:150-8. |
Hoffman J. Does prior adjuvant chemoradiotherapy lead to a safer pancreatoduodenectomy?.
ANNALS OF SURGICAL ONCOLOGY. 2006 Jan;13(1)
:7-9. |
Mullenix PS,
Brown TA,
Meyers MO,
Giles LR,
Sigurdson ER,
Boraas MC,
Hoffman JP,
Eisenberg BL,
Torosian MH. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
American Journal of Surgery. 2005 May;189(5)
:606-609. |
Koshy MC,
Landry JC,
Cavanaugh SX,
Fuller CD,
Willett CG,
Abrams RA,
Hoffman JP,
Thomas Jr CR. A challenge to the therapeutic nihilism of ESPAC-1.
International Journal of Radiation Oncology Biology Physics. 2005 ;61(4)
:965-966. |
Konski A,
Hoffman J,
Sigurdson E,
Haluszka O,
Engstrom P,
Cheng JD,
Cohen SJ,
Watson JC,
Eisenberg D,
McGarrity E,
Freedman G,
Meropol NJ. Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.
SEMINARS IN ONCOLOGY. 2005 Suppl.;32(6)
:S63-S67. |
Henry LR,
Sigurdson E,
Ross E,
Hoffman JP. Hydronephrosis does not preclude curative resection of pelvic recurrences after colorectal surgery.
Annals of Surgical Oncology. 2005 ;12(10)
:786-792. |
Subhi AL,
Tang B,
Balsara BR,
Altomare DA,
Testa JR,
Cooper HS,
Hoffman JP,
Meropol NJ,
Kruger WD. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
Clinical Cancer Research. 2004 Nov 1;10(21)
:7290-6. |
Berger AC,
Meszoely IM,
Ross EA,
Watson JC,
Hoffman JP. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.
Ann Surg Oncol. 2004 Jul;11(7)
:644-9. |
Meyers MO,
Meszoely IM,
Hoffman JP,
Watson JC,
Ross E,
Eisenberg BL. Is reporting of recurrence data important in pancreatic cancer?.
Annals of Surgical Oncology. 2004 Mar;11(3)
:304-309. |
Meszoely IM,
Lee JS,
Watson JC,
Meyers M,
Wang H,
Hoffman JP. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
American Surgeon. 2004 Mar;70(3)
:208-213. |
Berger AC,
Watson JC,
Ross EA,
Hoffman JP. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
American Surgeon. 2004 Mar;70(3)
:235-240. |
Hoffman JP. Does no good deed go unpunished? Notes to a young surgeon.
American Surgeon. 2004 Feb;70(2)
:97-100. |
Berger AC,
Watson JC,
Ross EA,
Zalatoris A,
Hoffman JP. Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma.
Am Surg. 2004 Feb;70(2)
:169-73; discussion 173-4. |
Altomare DA,
Tanno S,
De Rienzo A,
Klein-Szanto AJ,
Skele KL,
Hoffman JP,
Testa JR. Frequent activation of AKT2 kinase in human pancreatic carcinomas.
J Cell Biochem. 2003 Jan 1;88(1)
:470-6. |
Sasson AR,
Wetherington RW,
Hoffman JP,
Ross EA,
Cooper H,
Meropol NJ,
Freedman G,
Pingpank JF,
Eisenberg BL. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.
International Journal of Gastrointestinal Cancer. 2003 ;34(2-3)
:121-8. |
Pingpank JF Jr,
Hoffman JP,
Sigurdson ER,
Ross E,
Sasson AR,
Eisenberg BL. Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms.
Am Surg. 2002 Apr;68(4)
:337-40; discussion 340-1. |
Arnoletti JP,
Hoffman JP,
Ross EA,
Kagan SA,
Meropol NJ,
Freedman G,
Eisenberg B. Preoperative chemoradiation in the management of adenocarcinoma of the body of the pancreas.
Am Surg. 2002 Apr;68(4)
:330-5; discussion 335-6. |
Sasson AR,
Hoffman JP,
Ross EA,
Kagan SA,
Pingpank JF,
Eisenberg BL. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?.
J Gastrointest Surg. 2002 Mar-Apr;6(2)
:147-57; discussion 157-8. |
Watson JC,
Hoffman JP. Internal mammary lymph nodes: management and other controversies.
Breast Cancer: A Guide to Detection and Multidisciplinary Therapy. 2002
:295-312. |
Sasson AR,
Fowble B,
Hanlon AL,
Torosian MH,
Freedman G,
Boraas M,
Sigurdson ER,
Hoffman JP,
Eisenberg BL,
Patchefsky A. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
Cancer. 2001 May 15;91(10)
:1862-9. |
Pingpank JF,
Hoffman JP,
Ross EA,
Cooper HS,
Meropol NJ,
Freedman G,
Pinover WH,
LeVoyer TE,
Sasson AR,
Eisenberg BL. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas.
J Gastrointest Surg. 2001 Mar-Apr;5(2)
:121-30. |
Chao C,
Torosian MH,
Boraas MC,
Sigurdson ER,
Hoffman JP,
Eisenberg BL,
Fowble B. Local recurrence of breast cancer in the stereotactic core needle biopsy site: case reports and review of the literature.
Breast J. 2001 Mar-Apr;7(2)
:124-7. |
Sasson AR,
Hoffman JP,
Ross E,
Meropol NJ,
Szarka CE,
Freedman G,
Pinover W,
Pingpank JF,
Eisenberg BL. Trimodality therapy for advanced gallbladder cancer.
Am Surg. 2001 Mar;67(3)
:277-83; discussion 284. |
Langer CJ,
Hoffman JP,
Ottery FD. Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia.
Nutrition. 2001 Jan;17(1 Suppl)
:S1-20. |
Hoffman JP. Untitled.
Annals of Surgery. 2000 Nov;232(5)
:726-727. |
Iyer RV,
Hanlon A,
Fowble B,
Freedman G,
Nicolaou N,
Anderson P,
Hoffman J,
Sigurdson E,
Boraas M,
Torosian M. Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined.
Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5)
:1177-83. |
Fowble B,
Hanlon A,
Freedman G,
Nicolaou N,
Hoffman J,
Sigurdson E,
Boraas M,
Torosian M,
Goldstein L. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4)
:883-94. |
Chao C,
Goldberg M,
Hoffman JP. Surgical salvage therapy: abdominoperineal resection for recurrent anal carcinoma, metastasectomy of recurrent colorectal cancer, and esophagectomy after combined chemoradiation.
Curr Opin Oncol. 2000 Jul;12(4)
:353-6. |
Le Voyer TE,
Hoffman JP. Re: Local excision and chemoradiation for low rectal T-1 and T- 2 cancers is an effective treatment - Response.
American Surgeon. 2000 May;66(5)
:512-512. |
Padmore RF,
Fowble B,
Hoffman J,
Rosser C,
Hanlon A,
Patchefsky AS. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
Cancer. 2000 Mar 15;88(6)
:1403-9. |
Freedman GM,
Fowble BL,
Nicolaou N,
Sigurdson ER,
Torosian MH,
Boraas MC,
Hoffman JP. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?.
Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4)
:805-14. |
Coia LR,
Minsky BD,
Berkey BA,
John MJ,
Haller D,
Landry J,
Pisansky TM,
Willett CG,
Hoffman JP,
Owen JB,
Hanks GE. Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-1994 patterns of care study.
Journal of Clinical Oncology. 2000 Feb;18(3)
:455-462. |
Russell AH,
Harris J,
Rosenberg PJ,
Sause WT,
Fisher BJ,
Hoffman JP,
Kraybill WG,
Byhardt RW. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: Long-term results of Radiation Therapy Oncology Group Protocol 89-02.
International Journal of Radiation Oncology Biology Physics. 2000 Jan 15;46(2)
:313-322. |
Sauter ER,
Ehya H,
Babb J,
Diamandis E,
Daly M,
Klein-Szanto A,
Sigurdson E,
Hoffman J,
Malick J,
Engstrom PF. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.
Br J Cancer. 1999 Dec;81(7)
:1222-7. |
Coia LR,
Gunderson LL,
Haller D,
Hoffman J,
Mohiuddin M,
Tepper JE,
Berkey B,
Owen JB,
Hanks GE. Outcomes of patients receiving radiation for carcinoma of the rectum - Results of the 1988-1989 patterns of care study.
Cancer. 1999 Nov 15;86(10)
:1952-1958. |
Freedman G,
Fowble B,
Hanlon A,
Nicolaou N,
Fein D,
Hoffman J,
Sigurdson E,
Boraas M,
Goldstein L. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
International Journal of Radiation Oncology Biology Physics. 1999 Jul 15;44(5)
:1005-1015. |
Le Voyer TE,
Hoffman JP,
Cooper H,
Ross E,
Sigurdson E,
Eisenberg B. Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment.
Am Surg. 1999 Jul;65(7)
:625-30; discussion 630-1. |
Fowble B,
Hanlon A,
Freedman G,
Patchefsky A,
Kessler H,
Nicolaou N,
Hoffman J,
Sigurdson E,
Boraas M,
Goldstein L. Postmenopausal hormone replacement therapy: Effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Journal of Clinical Oncology. 1999 Jun;17(6)
:1680-1688. |
Movsas B,
Hanlon AL,
Lanciano R,
Scher RM,
Weiner LM,
Sigurdson ER,
Hoffman JP,
Eisenberg BL,
Cooper HS,
Provins S,
Coia LR. Phase I dose escalating trial of hyperfractionated pre- operative chemoradiation for locally advanced rectal cancer.
International Journal of Radiation Oncology Biology Physics. 1998 Aug 1;42(1)
:43-50. |
Fowble B,
Hanlon AL,
Patchefsky A,
Freedman G,
Hoffman JP,
Sigurdson ER,
Goldstein LJ. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
International Journal of Radiation Oncology Biology Physics. 1998 Aug 1;42(1)
:105-115. |
Pendurthi TK,
Hoffman JP,
Ross E,
Johnson DE,
Eisenberg BL. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
American Surgeon. 1998 Jul;64(7)
:686-692. |
Minsky BD,
Coia L,
Haller DG,
Hoffman J,
John M,
Landry J,
Pisansky TM,
Willett C,
Mahon I,
Owen J,
Berkey B,
Katz A,
Hanks G. Radiation therapy for rectosigmoid and rectal cancer: Results of the 1992-1994 patterns of care process survey.
Journal of Clinical Oncology. 1998 Jul;16(7)
:2542-2547. |
Freedman GM,
Fowble BL,
Hanlon AL,
Myint MA,
Hoffman JP,
Sigurdson ER,
Eisenberg BL,
Goldstein LJ,
Fein DA. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger.
International Journal of Radiation Oncology Biology Physics. 1998 Jun 1;41(3)
:599-605. |
Hoffman JP. Local excision for rectal cancer: An uncertain future.
Oncology-New York. 1998 Jun;12(6)
:944-+. |
Pelton JJ,
Hoffman JP,
Eisenberg BL. Comparison of liver function tests after hepatic lobectomy and hepatic wedge resection.
American Surgeon. 1998 May;64(5)
:408-414. |
Hoffman JP,
Pendurthi TK,
Ross E,
Yeung RSW. Preoperative radiation therapy and chemotherapy for adenocarcinoma of the pancreas.
Hepato-Gastroenterology. 1998 May-Jun;45(21)
:634-637. |
Katz A,
Hanlon A,
Lanciano R,
Hoffman J,
Coia L. Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy.
International Journal of Radiation Oncology Biology Physics. 1998 May 1;41(2)
:393-396. |
Minsky BD,
Coia L,
Haller D,
Hoffman J,
John M,
Landry J,
Pisansky TM,
Willett C,
Mahon I,
Owen J,
Hanks G. Treatment systems guidelines for primary rectal cancer from the 1996 patterns of care study.
International Journal of Radiation Oncology Biology Physics. 1998 Apr 1;41(1)
:21-27. |
Finlayson C,
Hoffman J,
Yeung R,
Kessler H,
Guttmann M,
Shaer A,
Clair M. Intraoperative ultrasound does not improve detection of liver metastases in resectable pancreatic cancer.
American Journal of Surgery. 1998 Feb;175(2)
:99-101. |
Hoffman JP,
Pendurthi TK,
Johnson DE. Management of exocrine carcinoma of the pancreas.
Cancer Treat Res. 1998 ;98
:65-82. |
Hoffman JP,
Lipsitz S,
Pisansky T,
Weese JL,
Solin L,
Benson AB. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An eastern cooperative oncology group study.
Journal of Clinical Oncology. 1998 Jan;16(1)
:317-323. |
Hoffman JP,
Cooper HS,
Young NA,
Pendurthi TK. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.
J Hepatobiliary Pancreat Surg. 1998 ;5(3)
:251-4. |
Johnson DE,
Hoffman JP. Sphincter preservation in rectal cancer. Surgical considerations for local excision.
Semin Radiat Oncol. 1998 Jan;8(1)
:39-47. |
Johnson DE,
Hoffman JP. Surgical considerations for local excision.
Seminars in Radiation Oncology. 1998 Jan;8(1)
:39-47. |
Hoffman JP,
Sigurdson ER,
Eisenberg BL. Use of saline-filled tissue expanders to protect the small bowel from radiation.
Oncology-New York. 1998 Jan;12(1)
:51-54. |
Freedman GM,
Fowble BL,
Hanlon AL,
Fein DA,
Hoffman JP,
Sigurdson ER,
Goldstein LJ. Postmastectomy radiation and adjuvant systemic therapy: outcomes in high-risk women with stage II-III breast cancer and assessment of clinical, pathologic, and treatment-related factors influencing local-regional control.
Breast Journal.. 1997 Nov-Dec;3(6)
:337-44. |
Montgomery RC,
Hoffman JP,
Riley LB,
Rogatko A,
Ridge JA,
Eisenberg BL. Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas.
Annals of Surgical Oncology. 1997 Oct-Nov;4(7)
:551-556. |
Johnson DE,
Pendurthi TK,
Balshem AM,
Ross E,
Litwin S,
Eisenberg BL,
Hoffman JP. Implications of fine-needle aspiration in patients with resectable pancreatic cancer.
American Surgeon. 1997 Aug;63(8)
:675-680. |
Fowble B,
Hanlon AL,
Fein DA,
Hoffman JP,
Sigurdson ER,
Patchefsky A,
Kessler H. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS).
International Journal of Radiation Oncology Biology Physics. 1997 Jul 15;38(5)
:949-957. |
Lattanzi JP,
Coia LR,
Scher RM,
Engstrom PF,
Hoffman JP,
Eisenberg BF,
Sigursdson ER,
Epstein BE,
Weiner LM. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver.
Gi Cancer. 1997 ;2(2)
:111-117. |
Yeh KA,
Fortunato L,
Hoffman JP,
Eisenberg BL. Cryosurgical ablation of hepatic metastases from colorectal carcinomas.
American Surgeon. 1997 Jan;63(1)
:63-67. |
Hoffman JP,
Odwyer P,
Agarwal P,
Salazar H,
Ahmad N. Preoperative chemoradiotherapy for localized pancreatic carcinoma - A perspective.
Cancer. 1996 Aug 1;78(3)
:592-597. |
Fowble B,
Fein DA,
Hanlon AL,
Eisenberg BL,
Hoffman JP,
Sigurdson ER,
Daly MB,
Goldstein LJ. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.
International Journal of Radiation Oncology Biology Physics. 1996 Jul 1;35(4)
:669-677. |
Sauter ER,
Hoffman JP,
Hartz WH,
Barber LW,
Eisenberg BL. Atraumatic method of intraoperative retrograde transhepatic biliary stent insertion.
Journal of Surgical Oncology. 1996 May;62(1)
:10-14. |
Fein DA,
Fowble BL,
Hanlon AL,
Hoffman JP,
Sigurdson ER,
Eisenberg BL. Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast- conserving surgery and irradiation?.
International Journal of Radiation Oncology Biology Physics. 1996 Mar 15;34(5)
:1009-1017. |
GercelTaylor C,
Hoffman JP,
Taylor DD,
Owens KJ,
Eisenberg BL. Interleukin-2 activation of cytotoxic cells in postmastectomy seroma.
Journal of Surgical Research. 1996 Feb 15;61(1)
:89-96. |
Odwyer PJ,
Hamilton TC,
LaCreta FP,
Gallo JM,
Kilpatrick D,
Halbherr T,
Brennan J,
Bookman MA,
Hoffman J,
Young RC,
Comis RL,
Ozols RF. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
Journal of Clinical Oncology. 1996 Jan;14(1)
:249-256. |
Hageboutros A,
Hudes GR,
Brennan J,
Green F,
Hoffman J,
LaCreta FP,
Colofiore J,
Martin DS,
Ozols RF,
Odwyer PJ. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L- aspartate and 6-methylmercaptopurine ribonucleoside.
Cancer Chemotherapy and Pharmacology. 1996 Jan;37(3)
:229-234. |
Dalton RR,
Lanciano RM,
Hoffman JP,
Eisenberg BL. Wound complications after resection and immediate postoperative brachytherapy in the management of soft-tissue sarcomas.
Annals of Surgical Oncology. 1996 Jan;3(1)
:51-56. |
Fortunato L,
Ahmad NR,
Yeung RS,
Coia LR,
Eisenberg BL,
Sigurdson ER,
Yeh K,
Weese JL,
Hoffman JP. Long-Term Follow-up of Local Excision and Radiation-Therapy for Invasive Rectal-Cancer.
Diseases of the Colon & Rectum. 1995 Nov;38(11)
:1193-1199. |
Ballard RB,
Hoffman JP,
Guttman MC,
Barber L,
Litwin S. How Accurate Is Size Measurement of Pancreas Cancer Masses by Computed Axial-Tomography (Ct) Scanning.
American Surgeon. 1995 Aug;61(8)
:686-691. |
Fein DA,
Lee WR,
Lanciano RM,
Corn BW,
Herbert SH,
Hanlon AL,
Hoffman JP,
Eisenberg BL,
Coia LR. Management of Extremity Soft-Tissue Sarcomas with Limb-Sparing Surgery and Postoperative Irradiation - Do Total-Dose, Overall Treatment Time, and the Surgery-Radiotherapy Interval Impact on Local-Control.
International Journal of Radiation Oncology Biology Physics. 1995 Jul 15;32(4)
:969-976. |
Fortunato L,
Clair M,
Hoffman J,
Sigurdson ER,
Sauter ER,
Barber LW,
Eisenberg B. Is Ct Portography (Ctap) Really Useful in Patients with Liver- Tumors Who Undergo Intraoperative Ultrasonography (Ious).
American Surgeon. 1995 Jul;61(7)
:560-565. |
Yeh KA,
Hoffman JP,
Kusiak JE,
Litwin S,
Sigurdson ER,
Eisenberg BL. Reconstruction with Myocutaneous Flaps Following Resection of Locally Recurrent Rectal-Cancer.
American Surgeon. 1995 Jul;61(7)
:581-589. |
Yeh KA,
Fortunato L,
Ridge JA,
Hoffman JP,
Eisenberg BL,
Sigurdson ER. Routine Bone Scanning in Patients with T1 and T2 Breast-Cancer - a Waste of Money.
Annals of Surgical Oncology. 1995 Jul;2(4)
:319-324. |
Coia L,
Hoffman J,
Scher R,
Weese J,
Solin L,
Weiner L,
Eisenberg B,
Paul A,
Hanks G. Preoperative Chemoradiation for Adenocarcinoma of the Pancreas and Duodenum.
International Journal of Radiation Oncology Biology Physics. 1994 Aug 30;30(1)
:161-167. |
Hoffman JP. Arterial Ports Versus Infusion Pumps.
Surgery. 1994 Jul;116(1)
:118-118. |
Hoffman JP,
Lanciano R,
Carp NZ,
Merrick MA,
Rosenblum NG,
Hogan WM,
Sigurdson ER,
Litwin S,
Eisenberg BL. Morbidity after Intraperitoneal Insertion of Saline-Filled Tissue Expanders for Small-Bowel Exclusion from Radiotherapy Treatment Fields - a Prospective 4-Year Experience with 34 Patients.
American Surgeon. 1994 Jul;60(7)
:473-483. |
Sauter ER,
Hoffman JP,
Ottery FD,
Kowalyshyn MJ,
Litwin S,
Eisenberg BL. Is Frozen-Section Analysis of Reexcision Lumpectomy Margins Worthwhile - Margin Analysis in Breast Reexcision.
Cancer. 1994 May 15;73(10)
:2607-2612. |
Coia L,
Wizenberg M,
Hanlon A,
Gunderson L,
Haller D,
Hoffman J,
Kline R,
Mohiuddin M,
Russell A,
Tepper J,
Owen J,
Hanks G. Evaluation and Treatment of Patients Receiving Radiation for Cancer of the Rectum or Sigmoid Colon in the United-States - Results of the 1988-1989 Patterns of Care Study Process Survey.
Journal of Clinical Oncology. 1994 May;12(5)
:954-959. |
Brophy PF,
Hoffman JP,
Eisenberg BL. The Pole of Palliative Pelvic Exenteration.
American Journal of Surgery. 1994 Apr;167(4)
:386-390. |
Fowble B,
Yeh IT,
Schultz DJ,
Solin LJ,
Rosato EF,
Jardines L,
Hoffman J,
Eisenberg B,
Weiss MC,
Hanks G. The Role of Mastectomy in Patients with Stage I-Ii Breast- Cancer Presenting with Gross Multifocal or Multicentric Disease or Diffuse Microcalcifications.
International Journal of Radiation Oncology Biology Physics. 1993 Oct 20;27(3)
:567-573. |
Sauter ER,
Hoffman JP,
Eisenberg BL. Diagnosis and Surgical-Management of Locally Recurrent Soft- Tissue Sarcomas of the Extremity .1.
Seminars in Oncology. 1993 Oct;20(5)
:451-455. |
Yeung RS,
Weese JL,
Hoffman JP,
Solin LJ,
Paul AR,
Engstrom PF,
Litwin S,
Kowalyshyn MJ,
Eisenberg BL. Neoadjuvant Chemoradiation in Pancreatic and Duodenal Carcinoma - a Phase-Ii Study.
Cancer. 1993 Oct 1;72(7)
:2124-2133. |
Odwyer PJ,
Lacreta FP,
Walczak J,
Cox T,
Litwin S,
Hoffman JP,
Zimny M,
Comis RL. Phase-I Pharmacokinetic Biochemical-Study of the Nitroimadazole Hypoxic Cell Sensitizer Sr2508 (Etanidazole) in Combination with Cyclophosphamide.
British Journal of Cancer. 1993 Oct;68(4)
:756-766. |
Fowler WC,
Hoffman JP,
Eisenberg BL. Redo Hepatic Resection for Metastatic Colorectal-Carcinoma.
World Journal of Surgery. 1993 Sep-Oct;17(5)
:658-662. |
Gwin JL,
Hoffman JP,
Eisenberg BL. Surgical-Management of Nonhepatic Intraabdominal Recurrence of Carcinoma of the Colon.
Diseases of the Colon & Rectum. 1993 Jun;36(6)
:540-544. |
Pelton JJ,
Lanciano RM,
Hoffman JP,
Hanks GM,
Eisenberg BL. The Influence of Surgical Margins on Advanced Cancer Treated with Intraoperative Radiation-Therapy (Iort) and Surgical Resection.
Journal of Surgical Oncology. 1993 May;53(1)
:30-35. |
Herbert SH,
Solin LJ,
Hoffman JP,
Schultz DJ,
Curran WJ,
Lanciano RM,
Rosenblum N,
Hogan M,
Eisenberg B,
Hanks GE. Volumetric-Analysis of Small-Bowel Displacement from Radiation Portals with the Use of a Pelvic Tissue Expander.
International Journal of Radiation Oncology Biology Physics. 1993 Apr 2;25(5)
:885-893. |
Sauter ER,
Eisenberg BL,
Hoffman JP,
Ottery FD,
Boraas MC,
Goldstein LJ,
Solin LJ. Postmastectomy Morbidity after Combination Preoperative Irradiation and Chemotherapy for Locally Advanced Breast-Cancer.
World Journal of Surgery. 1993 Mar-Apr;17(2)
:237-242. |
Hoffman JP,
Weese JL,
Solin LJ,
Agarwal P,
Engstrom P,
Scher R,
Paul AR,
Litwin S,
Watts P,
Eisenberg BL,
Sener SF,
Bouwman DL,
Aranha GV. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma.
American Surgeon. 1993 ;59(11)
:772-781. |
Gwin JL,
Eisenberg BL,
Hoffman JP,
Ottery FD,
Boraas M,
Solin LJ. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy.
Annals of Surgery. 1993 ;218(6)
:729-734. |
Hoffman JP,
Riley L,
Carp NZ,
Litwin S. Isolated locally recurrent rectal cancer: A review of incidence, presentation, and management.
Seminars in Oncology. 1993 ;20(5)
:506-519. |
Sauter ER,
Hoffman JP,
Eisenberg BL. Part I: Diagnosis and surgical management of locally recurrent soft- tissue sarcomas of the extremity.
Seminars in Oncology. 1993 ;20(5)
:451-455. |
Sauter ER,
Eisenberg BL,
Hoffman JP,
Ottery FD,
Boraas MC,
Goldstein LJ,
Solin LJ,
Kinne DW. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer.
World Journal of Surgery. 1993 ;17(2)
:237-242. |
Hoffman JP,
Kusiak JF,
Barreau-Pouhaer L,
Le MG,
Petit JY. Risk factors for failure of immediate breast reconstruction with prosthesis after total mastectomy for breast cancer.
Cancer. 1993 ;71(5)
:1931-1932. |
Pelton JJ,
Lanciano RM,
Hoffman JP,
Hanks GM,
Eisenberg BL,
Karakousis CP. The influence of surgical margins on advanced cancer treated with intraoperative radiation therapy (IORT) and surgical resection.
Journal of Surgical Oncology. 1993 ;53(1)
:30-35. |
Fowler WC,
Eisenberg BL,
Hoffman JP. Hepatic Resection Following Systemic Chemotherapy for Metastatic Colorectal-Carcinoma.
Journal of Surgical Oncology. 1992 Oct;51(2)
:122-125. |
Carp NZ,
Paul AR,
Kowalyshyn MJ,
Petersen RO,
Hoffman JP. Heterotopic Mucinous Cystadenoma of the Pancreas.
Digestive Diseases and Sciences. 1992 Aug;37(8)
:1297-1301. |
Pegues D,
Axelrod P,
McClarren C,
Eisenberg BL,
Hoffman JP,
Ottery FD,
Keidan RD,
Boraas M,
Weese J. Comparison of Infections in Hickman and Implanted Port Catheters in Adult Solid Tumor Patients.
Journal of Surgical Oncology. 1992 Mar;49(3)
:156-162. |
Rosenthal SA,
Yeung RS,
Weese JL,
Eisenberg BL,
Hoffman JP,
Coia LR,
Hanks GE. Conservative Management of Extensive Low-Lying Rectal Carcinomas with Transanal Local Excision and Combined Preoperative and Postoperative Radiation-Therapy - a Report of a Phase I-Ii Trial.
Cancer. 1992 Jan 15;69(2)
:335-341. |
Odwyer PJ,
Hudes GR,
Colofiore J,
Walczak J,
Hoffman J,
Lacreta FP,
Comis RL,
Martin DS,
Ozols RF. Phase-I Trial of Fluorouracil Modulation by N-Phosphonacetyl-L- Aspartate and 6-Methylmercaptopurine Riboside - Optimization of 6-Methylmercaptopurine Riboside Dose and Schedule through Biochemical-Analysis of Sequential Tumor-Biopsy Specimens.
Journal of the National Cancer Institute. 1991 Sep 4;83(17)
:1235-1240. |
Hoffman JP,
Kusiak J,
Boraas M,
Genter B,
Steuber K,
Weese JL,
Keidan RD,
Eisenberg BL,
Cox T,
Litwin S. Risk-Factors for Immediate Prosthetic Postmastectomy Reconstruction.
American Surgeon. 1991 Aug;57(8)
:514-522. |
Weese JL,
Nussbaum ML,
Paul AR,
Engstrom PF,
Solin LJ,
Kowalyshyn MJ,
Hoffman JP. Increased Resectability of Locally Advanced Pancreatic and Periampullary Carcinoma with Neoadjuvant Chemoradiotherapy.
International Journal of Pancreatology. 1990 Aug-Nov;7(1-3)
:177-185. |
Keidan RD,
Hoffman JP,
Weese JL,
Hanks GE,
Solin LJ,
Eisenberg BL,
Ottery FD,
Boraas M. Delayed Breast Abscesses after Lumpectomy and Radiation-Therapy.
American Surgeon. 1990 Jul;56(7)
:440-444. |
Palazzo JP,
Ellison DJ,
Garcia IE,
Langer C,
Scher RM,
Hoffman JP,
Petersen RO. Cutaneous Malacoplakia Simulating Relapsing Malignant-Lymphoma.
Journal of Cutaneous Pathology. 1990 Jun;17(3)
:171-175. |
|